Incyte (($INCY)) announced an update on their ongoing clinical study. Incyte Corporation is conducting a Phase 1, open-label, multicenter study ...

Doctors at Rome's Sant'Andrea hospital have performed a pulmonary artery transplant on a patient in their 70s with lung ...

A new study by investigators at Dana-Farber Cancer Institute and Harvard Medical School is providing one of the most detailed ...

Alethio Therapeutics Launches with New CEO and Chair to Advance Two Targeted Medicines for Myeloproliferative Neoplasms (Chronic Blood Cancers) ...

Please provide your email address to receive an email when new articles are posted on . Spitz neoplasms occurred most frequently between ages 31 and 40 years (22.4%). 20% of all Spitz neoplasm ...

The new classifications included several major changes and may help identify different subtypes. The fifth edition of the World Health Organization classification (2022 WHO) and the International ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Increases in wildfire-related fine particulate matter ...

Myeloproliferative neoplasm (MPN) represents a group of inflammatory diseases, including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). MPNs are linked to ...

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced updated data from an ...

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI) announced today that the National Institute of Biomedical Imaging and Bioengineering (an Institute within the National ...